Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Coumarins from Creston Apple Seeds: Isolation, Chemical Modification and Cytotoxicity Study

Yasser Fakri Mustafa, Moath Abdulla Najem, Zena Sideek Tawffiq.




Abstract

In the present work, preliminary phytochemical screening tests were performed on extracts of Creston apple seeds. Extraction was performed using two methods, which are serial Soxhlet extraction and kinetic maceration utilizing water, methanol, chloroform and n-hexane as extraction solvents. Three coumarin derivatives acquired from chloroform extract in the order of increasing polarity were isolated via column chromatography and one of them was chemically modified by esterification, Fries rearrangement and methylation afforded three semisynthetic derivatives. Detection of physicochemical properties and analysis of FTIR, 1H-NMR and 13C-NMR spectra of the natural and semisynthetic coumarins were used to identify their structures. In vitro cytotoxic activity of aforementioned coumarin derivatives was studied on three cancer cell lines, which are MCF-7, AMN3 and HeLa using MTT assay. The results indicated that compounds 3-6 have IC50 values lower than that of 5-fluorouracil against MCF-7 cell line and all compounds have higher IC50 values than that of 5-fluorouracil against AMN3 and HeLa cell lines.

Key words: Creston apple; phytochemical, coumarin derivative; cytotoxicity






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.